MiMedx Group, Inc. MDXG 深 沪
交易中 05-21 11:31:38 美东时间
3.675
-0.115
-3.03%
华盛通- 最 高3.73
- 今 开3.72
- 成交量 25.55万股
- 最 低 3.63
- 昨 收 3.79
- 总市值 5.47亿
- 52周最高 7.99
- 市盈率 静 11.33
- 换手率 0.17%
- 52周最低 3.025
- 委 比 -5.64%
- 总股本 1.49亿
- 历史最高 18.25
- 量 比 0.78
- 振 幅 2.64%
- 历史最低 0.83
- 每 手 1
- 风险率 1.29%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多MIMEDX Announces Launch of G4Derm® Plus
MiMedx Group, Inc. launched G4Derm Plus, a flowable biomimetic matrix with self-assembling peptide technology, to enhance wound management solutions. The product, now available through Premier and Vizient GPO agreements, offers advanced wound healing by promoting tissue regrowth and acting as an antibacterial barrier. Dr. John Lantis highlighted its potential to revolutionize patient care through its unique 3D scaffold and regenerative properties...
05-08 12:00
美股大行评级 | 潜在涨幅128.69%！Immunic获HC Wainwright & Co.升目标价至22美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Immunic"买入"评级，目标价从5美元升至22美元；花旗：维持ServiceNow"买入"评级，目标价从154美元升至158美元
05-01 10:49
CORRECTION: MiMedx Group Q1 Adj. EPS $(0.05) Misses $(0.03) Estimate, Sales $58.991M Miss $65.020M Estimate.
MiMedx Group (NASDAQ:MDXG) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.03) by 66.67 percent. This is a 183.33 percent decrease over earnings of $0.06 per share from
04-30 05:40
MiMedx Group shares are trading lower after the company reported worse-than-expected Q1 financial results and lowered its FY2026 sales guidance.
MiMedx Group shares are trading lower after the company reported worse-than-exp...
04-30 04:53
MiMedx Group Lowers FY2026 Sales Guidance from $340.000M-$360.000M to $260.000M-$290.000M vs $307.000M Est
MiMedx Group (NASDAQ:MDXG) lowers FY2026 sales outlook from $340.000 million-$360.000 million to $260.000 million-$290.000 million vs $307.000 million estimate.
04-30 04:12
Earnings Scheduled For April 29, 2026
Companies Reporting Before The Bell • Extreme Networks (NASDAQ:EXTR) is likely ...
04-29 19:11
美股大行评级 | 大摩上调Lumentum目标价从595美元升至710美元；康宁、道富银行、Ally Financial获多家机构上调目标价
今日重点评级关注：Canaccord Genuity：维持Vertical Aerospace"买入"评级，目标价从9.5美元升至10.5美元；Canaccord Genuity：维持AtaiBeckley Inc."买入"评级，目标价从14美元升至15美元
04-21 11:25
美股大行评级 | 美银证券上调闪迪目标价从900美元升至1080美元；纽约梅隆银行、Onto Innovation、安博、美国合众银行等获多家大行上调目标价
今日重点评级关注：Guggenheim：维持AtaiBeckley Inc."买入"评级，目标价从11美元升至16美元；RBC Capital：维持MeiraGTx Holdings"跑赢大市"评级，目标价从16美元升至24美元
04-20 11:33
MiMedx Group shares are trading lower after the company announced a restructuring and cost-cutting plans.
MiMedx Group shares are trading lower after the company announced a restructuri...
04-16 22:52
MiMedx launches restructuring to cut costs, refocus growth
MiMedx Group ( ($MDXG) ) has provided an announcement. On April 14, 2026, MiMed...
04-16 21:27
